|
||
|
TAS levels in T2DM patients and non-diabetic controls. T2DM: type 2 diabetes; control group: non-diabetic controls; ** p<0.01 versus control. Values are mean ± SD, Mann-Whitney U test; SD: Standard deviation, min and max |
|
||||||||
| Part of: Sabancilar I, Unsal V, Demir F, Toprak G, Pekkolay Z (2023) Does oxidative status affect serum sclerostin levels in patients with type 2 diabetes mellitus? Folia Medica 65(1): 46-52. https://doi.org/10.3897/folmed.65.e72953 |